Vaccine News and Research

Latest Vaccine News and Research

INTEGRA pipetting solutions accelerate crucial viral genomics research

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

From INTEGRA Biosciences 14 Jul 2023

KFF Health News' 'What the Health?': The long road to reining in short-term plans

It took more than two years, but the Biden administration has finally kept a promise made by then-candidate Joe Biden to roll back the Trump administration's expansion of short-term, limited-duration health plans.

13 Jul 2023

Wait, What’s a PBM?

Pharmacy benefit managers, or PBMs, are intermediary companies that negotiate the price of prescription drugs.

13 Jul 2023

COVID-19 excess mortality measured by the Global Health Security Index

Researchers compare COVID-19 excess mortality rates across 183 countries.

13 Jul 2023

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Researchers identify patient groups at a higher risk of death due to COVID-19 among adults who received a second booster dose in England.

12 Jul 2023

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

7DW8-5, a glycolipid that utilizes the body's non-specific immune response to quickly combat viral infections, including COVID-19 in vivo.

11 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

FOUR PAWS highlights World Zoonoses Day 2023 and outbreak of Highly Pathogenic Avian Influenza

Today, on World Zoonosis Day, global animal welfare organisation FOUR PAWS flags that governments have not learnt the lesson from COVID-19 that human, environmental and animal health must be addressed together to prevent another pandemic.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Tick season is here: How to avoid ticks

It's tick season now and researchers from the University of Agder in Norway shed light on the myths and facts about these parasites.

7 Jul 2023

New vaccine protects infant monkeys from diarrhea and promotes growth

A vaccine originally developed to prevent bacteria-caused diarrhea has now also been found to help infant nonhuman primates grow faster, according to a new study published in Nature Communications.

6 Jul 2023

Mobile phone data may not accurately represent under-resourced or vulnerable populations

Mobile phone data are increasingly used in public health management and disease outbreak response, as demonstrated during the COVID-19 pandemic when location data were used as a proxy for human movement and contacts and informed exposure notification apps.

6 Jul 2023

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

6 Jul 2023

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023